Inducing remission in ANCA-positive vasculitis: time to RAVE? Richard A. Watts 1 Nature Reviews Rheumatology volume 6 , pages 127–128 ( 2010 ) Cite this article ...

Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

RENAL-F02 is an ongoing Phase 2 study in Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV) with Rapidly Progressive Glomerulonephritis (RPGN) (NCT06047171), where 26 patients ...